BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 20738008)

  • 1. Imaging as a means of studying chemotherapy-related cognitive impairment.
    Raffa RB
    Adv Exp Med Biol; 2010; 678():70-6. PubMed ID: 20738008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is a picture worth a thousand (forgotten) words?: neuroimaging evidence for the cognitive deficits in 'chemo-fog'/'chemo-brain'.
    Raffa RB
    J Clin Pharm Ther; 2010 Feb; 35(1):1-9. PubMed ID: 20175809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemo fog: cancer chemotherapy-related cognitive impairment. Preface.
    Raffa RB; Tallarida RJ
    Adv Exp Med Biol; 2010; 678():vii-viii. PubMed ID: 20737998
    [No Abstract]   [Full Text] [Related]  

  • 4. Chemotherapy-related visual system toxicity.
    Raffa RB
    Adv Exp Med Biol; 2010; 678():113-8. PubMed ID: 20738012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient's perspective.
    Raffa RB; Martin KJ
    Adv Exp Med Biol; 2010; 678():11-2. PubMed ID: 20738000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropsychologic testing for chemotherapy-related cognitive impairment.
    Myers JS
    Adv Exp Med Biol; 2010; 678():55-69. PubMed ID: 20738007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The (mis)classification of chemo-fog--methodological inconsistencies in the investigation of cognitive impairment after chemotherapy.
    Shilling V; Jenkins V; Trapala IS
    Breast Cancer Res Treat; 2006 Jan; 95(2):125-9. PubMed ID: 16261398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [An overview of the research of cancer-related cognitive impairment].
    Ferencz V; S Nagy Z; Tóth M
    Orv Hetil; 2019 Sep; 160(38):1495-1502. PubMed ID: 31537098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short introduction and history.
    Raffa RB
    Adv Exp Med Biol; 2010; 678():1-10. PubMed ID: 20737999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurocognitive changes in cancer survivors.
    Correa DD; Ahles TA
    Cancer J; 2008; 14(6):396-400. PubMed ID: 19060604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Future directions.
    Raffa RB; Tallarida RJ
    Adv Exp Med Biol; 2010; 678():165-7. PubMed ID: 20738019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of chemotherapy-induced cognitive disorders: neuropsychological, pathophysiological, and neuroimaging perspectives.
    Saykin AJ; Ahles TA; McDonald BC
    Semin Clin Neuropsychiatry; 2003 Oct; 8(4):201-16. PubMed ID: 14613048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive impairment associated with chemotherapy for cancer: report of a workshop.
    Tannock IF; Ahles TA; Ganz PA; Van Dam FS
    J Clin Oncol; 2004 Jun; 22(11):2233-9. PubMed ID: 15169812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemo brain (chemo fog) as a potential side effect of doxorubicin administration: role of cytokine-induced, oxidative/nitrosative stress in cognitive dysfunction.
    Aluise CD; Sultana R; Tangpong J; Vore M; St Clair D; Moscow JA; Butterfield DA
    Adv Exp Med Biol; 2010; 678():147-56. PubMed ID: 20738017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is 'chemo-fog'/'chemo-brain' caused by cancer chemotherapy?
    Raffa RB; Duong PV; Finney J; Garber DA; Lam LM; Mathew SS; Patel NN; Plaskett KC; Shah M; Jen Weng HF
    J Clin Pharm Ther; 2006 Apr; 31(2):129-38. PubMed ID: 16635046
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects on the visual system might contribute to some of the cognitive deficits of cancer chemotherapy-induced 'chemo-fog'.
    Raffa RB; Tallarida RJ
    J Clin Pharm Ther; 2010 Jun; 35(3):249-55. PubMed ID: 20831527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neural correlates of chemotherapy-related cognitive impairment.
    Kaiser J; Bledowski C; Dietrich J
    Cortex; 2014 May; 54():33-50. PubMed ID: 24632463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The economic burden.
    Wertheimer AI
    Adv Exp Med Biol; 2010; 678():33-6. PubMed ID: 20738005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemobrain: a systematic review of structural and functional neuroimaging studies.
    Simó M; Rifà-Ros X; Rodriguez-Fornells A; Bruna J
    Neurosci Biobehav Rev; 2013 Sep; 37(8):1311-21. PubMed ID: 23660455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive adverse effects of chemotherapy in breast cancer patients.
    Correa DD; Ahles TA
    Curr Opin Support Palliat Care; 2007 Apr; 1(1):57-62. PubMed ID: 18660726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.